To Assess Effects of Arbaclofen ER Tablets Compared With Placebo on Sperm Parameters in Male Subjects With MS

NCT02869425 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped suspended due to inability to enroll subjects

Conditions

Multiple Sclerosis
Sperm

Interventions

DRUG: arbaclofen ER Tablets
DRUG: Placebo for arbaclofen ER tablets

Sponsor

RVL Pharmaceuticals, Inc.

Collaborators

[object Object]